Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer

BACKGROUND: Much research has confirmed the favorable effect of irinotecan/cisplatin (IP) and etoposide/cisplatin (EP) on extensive-stage small cell lung cancer (E-SCLC). This study investigated two sequential orders of IP and EP in the treatment of E-SCLC. We also compared the efficacy and safety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Xiaoguang, Wang, Shujing, Xia, Shu, Zou, Man, Li, Yang, Wei, Yao, Mei, Qi, Chen, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551306/
https://www.ncbi.nlm.nih.gov/pubmed/26345293
http://dx.doi.org/10.2147/OTT.S89606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551306/
https://www.ncbi.nlm.nih.gov/pubmed/26345293
http://dx.doi.org/10.2147/OTT.S89606

Ejemplares similares